Catawba Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $2.79M | Buy |
50,384
+633
| +1% | +$35K | 0.66% | 53 |
|
|
2018
Q1 | $3.15M | Buy |
49,751
+175
| +0.4% | +$11.1K | 0.76% | 49 |
|
|
2017
Q4 | $3.04M | Sell |
49,576
-123
| -0.2% | -$7.54K | 0.69% | 51 |
|
|
2017
Q3 | $3.17M | Sell |
49,699
-400
| -0.8% | -$25.5K | 0.72% | 50 |
|
|
2017
Q2 | $2.79M | Sell |
50,099
-2,636
| -5% | -$147K | 0.64% | 57 |
|
|
2017
Q1 | $2.87M | Sell |
52,735
-1,130
| -2% | -$61.5K | 0.63% | 57 |
|
|
2016
Q4 | $3.15M | Sell |
53,865
-341
| -0.6% | -$19.9K | 0.74% | 49 |
|
|
2016
Q3 | $2.92M | Buy |
54,206
+2,760
| +5% | +$149K | 0.69% | 50 |
|
|
2016
Q2 | $3.78M | Sell |
51,446
-1,000
| -2% | -$73.6K | 0.92% | 39 |
|
|
2016
Q1 | $3.35M | Sell |
52,446
-2,125
| -4% | -$136K | 0.85% | 44 |
|
|
2015
Q4 | $3.75M | Sell |
54,571
-1,291
| -2% | -$88.8K | 1.02% | 30 |
|
|
2015
Q3 | $3.31M | Sell |
55,862
-5,845
| -9% | -$346K | 0.91% | 37 |
|
|
2015
Q2 | $4.11M | Buy |
61,707
+5,150
| +9% | +$343K | 0.98% | 35 |
|
|
2015
Q1 | $3.65M | Sell |
56,557
-210
| -0.4% | -$13.5K | 0.84% | 40 |
|
|
2014
Q4 | $3.35M | Sell |
56,767
-200
| -0.4% | -$11.8K | 0.77% | 45 |
|
|
2014
Q3 | $2.92M | Sell |
56,967
-300
| -0.5% | -$15.4K | 0.68% | 53 |
|
|
2014
Q2 | $2.78M | Sell |
57,267
-55
| -0.1% | -$2.67K | 0.63% | 58 |
|
|
2014
Q1 | $2.98M | Sell |
57,322
-113
| -0.2% | -$5.87K | 0.71% | 49 |
|
|
2013
Q4 | $3.05M | Sell |
57,435
-230
| -0.4% | -$12.2K | 0.73% | 51 |
|
|
2013
Q3 | $2.67M | Sell |
57,665
-830
| -1% | -$38.4K | 0.7% | 55 |
|
|
2013
Q2 | $2.61M | Buy |
+58,495
| New | +$2.61M | 0.73% | 54 |
|